PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
15-Oct-2025 Merck to Acquire the Chromatography Business of JSR Life Sciences, Expanding Protein A Capabilities and Downstream Portfolio Businesswire
15-Oct-2025 Eradivir’s EV25 Shows Promising Results in Phase 2a Trial for the Treatment of Influenza Businesswire
15-Oct-2025 NEUPATH HEALTH TO PRESENT AT THE PLANET MICROCAP SHOWCASE: TORONTO IN PARTNERSHIP WITH THE MICROCAPCLUB ON WEDNESDAY, OCTOBER 22, 2025 Businesswire
15-Oct-2025 OncoNano Medicine Announces Presentation at AACR-NIC-EORTC International Conference on Molecular Targets and Cancer Therapeutics Businesswire
15-Oct-2025 Pelage Pharmaceuticals Announces $120 Million Series B Financing to Advance Regenerative Medicine Treatments for Hair Loss Businesswire
15-Oct-2025 MindWalk Appoints Dr. Thomas W. Lynch as Chief Business Officer to Accelerate Commercial Expansion Businesswire
15-Oct-2025 Alentis Appoints Mark Pruzanski as CEO Businesswire
15-Oct-2025 United Therapeutics Corporation to Report Third Quarter 2025 Financial Results Before Market Open on Wednesday, October 29, 2025 Businesswire
15-Oct-2025 Merck Announces New Data from Phase 3 Trials Evaluating the Investigational, Once-Daily, Oral, Two-Drug Regimen of Doravirine/Islatravir (DOR/ISL) in Adults with Virologically Suppressed HIV-1 Infection Businesswire
15-Oct-2025 Frontier Scientific Solutions and Air Transport Services Group Announce Strategic Partnership to Launch Dedicated Air Services for Life Sciences Businesswire
15-Oct-2025 Tubulis Raises €308 Million Series C to Accelerate Clinical Development of Lead ADC Candidate TUB-040 and Expand Pipeline Businesswire
15-Oct-2025 ADOCIA and Tonghua Dongbao Announce Positive Topline Results of Phase 3 Clinical Trial on Ultra-Rapid Insulin BioChaperone® Lispro (THDB0206 injection) in people with T1D Businesswire
15-Oct-2025 ADOCIA et Tonghua Dongbao annoncent les résultats positifs de l'essai clinique de Phase 3 sur l'insuline ultra-rapide BioChaperone® Lispro (THDB0206 injection) chez les personnes atteintes de Diabète de Type 1 Businesswire
15-Oct-2025 Omnix Medical Secures $25 Million in Series C Funding Co-Led by Harel Insurance & Finance and the EIC Fund Omnix Medical
15-Oct-2025 Orum Therapeutics Appoints Dr. Dorin Toader as Head of Platform Technology to Advance Orum’s Degrader–Antibody Conjugate Payload Platforms and Expand TPD²® Therapeutic Applications Businesswire
14-Oct-2025 Generational Group Advises REET Corporation in its Sale to Barry R. Haas Businesswire
14-Oct-2025 Paysign to Host Third Quarter 2025 Earnings Call Businesswire
14-Oct-2025 New Zealand Healthcare Industry Market Databook 2025 | 300+ KPIs Covering Healthcare Infrastructure, Patient Demographics, Diagnostics, Public and Private Spending, Clinical and Non-Clinical Workforce - ResearchAndMarkets.com Businesswire
14-Oct-2025 Cannabis Market Forecast Report 2025-2033: Increasing Consumer Demand, New Medicinal Uses, and Changing Regulatory Environments - ResearchAndMarkets.com Businesswire
14-Oct-2025 Global CD276 Targeted Therapies Clinical Trials & Market Opportunity Insight 2026 - ResearchAndMarkets.com Businesswire